Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Recall of Albumin (Human) 25 %, Albuminar, ZLB Behring LLC


August 29, 2005


Albumin (Human) 25%, Albuminar, 100 mL

C934009     9/16/2007
C934110     10/5/2007


ZLB Behring L.L.C.
King of Prussia, PA


Lots C934009 and C934110 are being recalled as a precautionary measure. One bottle of Albuminar in Japan has been found with a stopper defect that may allow product leakage. The same stopper batch as that used in Japan was also used on these two lots. As of this date, there are no technical complaints or adverse events reported against either lot. The firm is requesting that the use of these lots be immediately discontinued and that the product be returned to the manufacturer for credit.

Updated information

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 06/26/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English